Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome (Q45183880)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 November 2004
edit
Language Label Description Also known as
English
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
scientific article published on 30 November 2004

    Statements

    Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome (English)
    M A Aloe Spiriti
    M Tambone Reyes

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit